# Usage of nanobody-beta-galactosidase fusion in immunoassays and its application in detecting a peanut allergen

## TL;DR

Researchers created a nanobody-beta-galactosidase fusion to detect peanut allergens more effectively than traditional methods.

## Contribution

A nanobody fused with beta-galactosidase was developed for immunoassays, showing improved detection of peanut allergens.

## Key findings

- The Nb16-beta-gal fusion detected Ara h 3 with a 0.3 ppm limit, better than HRP.
- Stable signals from S-Gal/X-Gal showed beta-gal's benefits in immunoblots.
- Easy production of Nb-beta-gal chimeras suggests future widespread use.

## Abstract

Small-sized nanobodies (NBs) offer many advantages over traditional antibodies and antibody fragments. β-Galactosidase (β-gal) has been used as a detection enzyme in immunoassays when horseradish peroxidase (HRP) or alkaline phosphatase (ALP) could not be used. However, more research is needed to fully realize the benefits of using β-gal in immunoassays. This study fused a previously isolated NB specific to peanut allergen Ara h 3 (Nb16) with the tetrameric Escherichia coli β-gal. Kinetic signals generated using ONPG demonstrated the advantage of using β-gal in ELISA experiments. Peanut allergen Ara h 3 was successfully detected with the Nb16-β-gal, with a detection limit of 0.3 ppm, outperforming detection with the same NB and HRP. For detecting peanut proteins in baked foods, the detection limit was better than 1.56 ppm. Stable signals produced with S-Gal/X-Gal showed the benefits of using β-gal in immunoblots. The readily available, stable β-gal substrates and the ease of recombinant production of NB-β-gal chimeras are among the advantages of using β-gal over HRP and ALP as detection enzymes in immunoassays.

•A fusion of E.coli β-gal and a nanobody against a peanut allergen was produced.•The utility and advantages of β-gal in immunoassays were demonstrated.•Low-cost substrates and stable signals showed β-gal's advantage over HRP and ALP.•Easy production of Nb-β-gal chimeras signified their widespread use in the future.

A fusion of E.coli β-gal and a nanobody against a peanut allergen was produced.

The utility and advantages of β-gal in immunoassays were demonstrated.

Low-cost substrates and stable signals showed β-gal's advantage over HRP and ALP.

Easy production of Nb-β-gal chimeras signified their widespread use in the future.